analyst Tim Ramey reiterated a Buy rating and raised his price target on Herbalife (NYSE: HLF) from $78 to $92 following strong Q2 EPS of $1.41, up 28% YOY.
"We are increasing our EPS estimates for FY13 and FY14 by a dime to $5.00 and $5.75, respectively," the analyst said. "We remain ahead of guidance due to our assumption that margins will expand and share repurchase will continue in Q4."
For an analyst ratings summary and ratings history on Herbalife click here. For more ratings news on Herbalife click here